LOX and LOXL2 Expression in Canine Mammary Carcinomas
Veterinary and Comparative Oncology · 2026
DOI: 10.1111/vco.70036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2026. Verfasst von Jessika Daniel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, Laboratory of Comparative and Translational Oncology (LOCT-USP), School of Animal Science and Food Engineering, Un…. Hauptthemen laut MEDLINE: Mammary Neoplasms, Animal, Dog Diseases, Amino Acid Oxidoreductases, Protein-Lysine 6-Oxidase. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Mammary tumours account for approximately 50% of the neoplasms in female dogs. Even conventionally accepted prognostic indicators often fail to reliably predict the clinical behaviour of these tumours, underscoring the need for more effective prognostic markers. Proteins of the LOX family are associated with tumour invasion and metastasis in several types of tumours. The purpose of this study was to characterise the immunohistochemical expression of LOX and LOXL2 in canine mammary carcinomas and to investigate their prognostic significance. Samples of mammary carcinomas from 80 female dogs with a minimum post‐surgical follow‐up of 180 days were analysed. Tumour samples were submitted to immunohistochemistry to detect LOX and LOXL2. Immunolabelling was evaluated based on scores for staining intensity and percentage of positive cells, and a combined score was used to classify each protein as having either ‘low‐’ or ‘high‐expression’. The results were compared with histological types, mortality due to the disease and post‐surgical survival. We found that negativity for LOXL2 expression was an indicator of higher risk of death due to the disease. Our results suggest that lysyl oxidases such as LOXL2 are potential prognostic markers in mammary carcinomas of dogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medicine, Laboratory of Comparative and Translational Oncology (LOCT-USP), School of Animal Science and Food Engineering, University of São Paulo (FZEA-USP), Pirassununga, São Paulo, Brazil.
- Veterinary Pathology Service, Department of Pathology, Reproduction and One Health, Faculty of Agricultural and Veterinary Sciences, São Paulo State University (FCAV-UNESP), Jaboticabal, São Paulo, Brazil.
- Veterinary Oncology Service (SOV), Faculty of Agricultural and Veterinary Sciences, São Paulo State University (FCAV-UNESP), Jaboticabal, São Paulo, Brazil.
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil.
ORCID-Profile: Andrigo Barboza De Nardi, Ricardo De Francisco Strefezzi
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Daniel, J., Silva, I. K. L., Vasconcelos, R. O., Cabral, A. P. M., De Nardi, A. B., Sangalli, J. R., & Strefezzi, R. F. (2026). LOX and LOXL2 Expression in Canine Mammary Carcinomas. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.70036
Vancouver
Daniel J, Silva IKL, Vasconcelos RO, Cabral APM, De Nardi AB, Sangalli JR, et al. LOX and LOXL2 Expression in Canine Mammary Carcinomas. Veterinary and Comparative Oncology. 2026. doi:10.1111/vco.70036
BibTeX
@article{Daniel2026,
author = {Daniel, Jessika and Silva, Ingrid Kester Lima and Vasconcelos, Rosemeri de Oliveira and Cabral, Adilson Paulo Marchioni and De Nardi, Andrigo Barboza and Sangalli, Juliano Rodrigues and Strefezzi, Ricardo De Francisco},
title = {LOX and LOXL2 Expression in Canine Mammary Carcinomas},
journal = {Veterinary and Comparative Oncology},
year = {2026},
doi = {10.1111/vco.70036}
}
EUVIMED